These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16506357)

  • 1. Life-threatening bradyarrhythmia after massive azithromycin overdose.
    Tilelli JA; Smith KM; Pettignano R
    Pharmacotherapy; 2006 Jan; 26(1):147-50. PubMed ID: 16506357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.
    Thomsen MB; Beekman JD; Attevelt NJ; Takahara A; Sugiyama A; Chiba K; Vos MA
    Br J Pharmacol; 2006 Dec; 149(8):1039-48. PubMed ID: 17088870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Azithromycin-Induced Life-Threatening Arrhythmia Requiring Extracorporeal Membrane Oxygenation Support: A Case Report.
    Al-Jazairi AS; Alotaibi HS
    Am J Case Rep; 2020 Nov; 21():e926951. PubMed ID: 33180749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
    Kezerashvili A; Khattak H; Barsky A; Nazari R; Fisher JD
    J Interv Card Electrophysiol; 2007 Apr; 18(3):243-6. PubMed ID: 17546486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of astemizole and ketoconazole resulting in torsade de pointes.
    Tsai WC; Tsai LM; Chen JH
    J Formos Med Assoc; 1997 Feb; 96(2):144-6. PubMed ID: 9071844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.
    Niedrig D; Maechler S; Hoppe L; Corti N; Kovari H; Russmann S
    Eur J Clin Pharmacol; 2016 Jul; 72(7):859-67. PubMed ID: 27023463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmias after astemizole overdose.
    Heidemann SM; Sarnaik AP
    Pediatr Emerg Care; 1996 Apr; 12(2):102-4. PubMed ID: 8859918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradycardia and Hypothermia Complicating Azithromycin Treatment.
    Benn K; Salman S; Page-Sharp M; Davis TME; Buttery JP
    Am J Case Rep; 2017 Aug; 18():883-886. PubMed ID: 28798290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
    Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms.
    Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA
    Pharmacotherapy; 2020 Feb; 40(2):107-115. PubMed ID: 31867748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin-Induced Bradycardia.
    Abdelazeem B; Hollander RM; Ayad S; Gergis K; Gismalla ME
    Cureus; 2021 Aug; 13(8):e16995. PubMed ID: 34540397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT prolongation associated with azithromycin/amiodarone combination.
    Samarendra P; Kumari S; Evans SJ; Sacchi TJ; Navarro V
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1572-4. PubMed ID: 11707055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric basic life support.
    American Heart Association
    Pediatrics; 2006 May; 117(5):e989-1004. PubMed ID: 16651298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin and the risk of cardiovascular complications.
    Maisch NM; Kochupurackal JG; Sin J
    J Pharm Pract; 2014 Oct; 27(5):496-500. PubMed ID: 25374989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.